Connect Investigative Site 203

Guangzhou, Guangdong 510080

0 studies enrolling now · 1 studies all time

What they study most

Moderate to Severe Persistent Asthma

Studies at this site

• Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation — Completed